Medications dispensed from the Saskatchewan Cancer Agency (SCA) on or after August 29, 2022 will start appearing on the Pharmaceutical Information Program (PIP) and downstream applications such as MySask Health Record and eHealth eHR Viewer.
This addition will improve patient care by providing a more complete patient medication profile on which to base treatment decisions.
Healthcare providers with medication management and reconciliation responsibilities can review a short video and update resource about SCA medication integration in PIP on the Medication Reconciliation intranet page.
SHA Update Notification: Cancer Medications Appearing on PIP
The recent amendment to bylaw 18.1 permits part-fills for some PRP medications (baclofen, chloral hydrate, gabapentin, oxybutynin, pregabalin, lemborexant and zopiclone) without the federal written requirements of opioids, benzodiazepines, stimulants and anabolic steroids.
See the examples linked below illustrating the amendment, whereby the total quantity, amount to be dispensed each time, and time interval between fills relating to part-fills are no longer required for baclofen, chloral hydrate, gabapentin, oxybutynin, pregabalin, lemborexant and zopiclone.
Sample scripts PDF
The CRNS (formerly the Saskatchewan Registered Nurses Association, SRNA) has moved to new spaces! As of September 20, 2022, the new address is:
1-3710 Eastgate Drive, Regina, SK S4Z 1A5
The following numbers remain the same:
Toll free 1-800-667-9945
Fax number: 306-359-0257
Email address: firstname.lastname@example.org
Click here to access a series of useful practice tools.